Cargando…
MYL2-associated congenital fiber-type disproportion and cardiomyopathy with variants in additional neuromuscular disease genes; the dilemma of panel testing
Next-generation sequencing has led to transformative advances in our ability to diagnose rare diseases by simultaneously sequencing dozens, hundreds, or even entire genomes worth of genes to efficiently identify pathogenic mutations. These studies amount to multiple hypothesis testing on a massive s...
Autores principales: | Marttila, Minttu, Win, Wathone, Al-Ghamdi, Fouad, Abdel-Hamid, Hoda Z., Lacomis, David, Beggs, Alan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672024/ https://www.ncbi.nlm.nih.gov/pubmed/31127036 http://dx.doi.org/10.1101/mcs.a004184 |
Ejemplares similares
-
Autosomal recessive cardiomyopathy and sudden cardiac death associated with variants in MYL3
por: Osborn, Daniel Peter Sayer, et al.
Publicado: (2020) -
Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice
por: Yuan, Chen-Ching, et al.
Publicado: (2018) -
Valsartan inhibits RhoA-ROCK2-MYL pathway in rat model of alcoholic cardiomyopathy
por: Li, Luyifei, et al.
Publicado: (2019) -
MYL-1402O: A Bevacizumab Biosimilar
por: Lee, Arnold
Publicado: (2021) -
Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy
por: Manivannan, Sathiya N., et al.
Publicado: (2020)